0001209191-15-010571.txt : 20150206 0001209191-15-010571.hdr.sgml : 20150206 20150206212753 ACCESSION NUMBER: 0001209191-15-010571 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150204 FILED AS OF DATE: 20150206 DATE AS OF CHANGE: 20150206 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Paratek Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001178711 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330960223 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 75 KNEELAND STREET STREET 2: 6TH FLOOR CITY: BOSTON STATE: MA ZIP: 02111 BUSINESS PHONE: (617) 275-0040 MAIL ADDRESS: STREET 1: 75 KNEELAND STREET STREET 2: 6TH FLOOR CITY: BOSTON STATE: MA ZIP: 02111 FORMER COMPANY: FORMER CONFORMED NAME: Transcept Pharmaceuticals Inc DATE OF NAME CHANGE: 20090130 FORMER COMPANY: FORMER CONFORMED NAME: NOVACEA INC DATE OF NAME CHANGE: 20020724 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stein Jeffrey CENTRAL INDEX KEY: 0001478831 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36066 FILM NUMBER: 15586539 MAIL ADDRESS: STREET 1: 6310 NANCY RIDGE DRIVE, SUITE 101 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-02-04 0 0001178711 Paratek Pharmaceuticals, Inc. PRTK 0001478831 Stein Jeffrey C/O PARATEK PHARMACEUTICALS, INC. 75 KNEELAND STREET BOSTON MA 02111 1 0 0 0 Stock Option (right to buy) 24.07 2015-02-04 4 A 0 20000 0.00 A 2025-02-03 Common Stock 20000 20000 D The exercise price is equal to the closing sales price per share of Common Stock as reported on The Nasdaq Global Market on the date of grant. 1/36th of the shares vest on a monthly basis. /s/ Michael Bigham, Attorney-in-Fact for Jeffrey Stein 2015-02-06